Uhlyarik A - Search Results

1

[Laparoscopic resection of a liver metastasis from segment VII. Case report].

Dede K, Papp G, Salamon F, Uhlyarik A, Bursics A. Dede K, et al. Among authors: uhlyarik a. Orv Hetil. 2016 May 15;157(20):796-800. doi: 10.1556/650.2016.30431. Orv Hetil. 2016. PMID: 27156527 Hungarian.

2

[Diagnosis and treatment options of neuroendocrine tumours].

Uhlyarik A, Pápai Z. Uhlyarik A, et al. Orv Hetil. 2013 Sep 29;154(39):1549-55. doi: 10.1556/OH.2013.29716. Orv Hetil. 2013. PMID: 24058100 Review. Hungarian.

3

[Treatment of metastatic midgut neuroendocrine tumour associated with carcinoid syndrome].

Uhlyarik A, Lahm E, Vachaja J, Pápai Z. Uhlyarik A, et al. Orv Hetil. 2014 Feb 1;155(5):194-8. doi: 10.1556/OH.2014.29818. Orv Hetil. 2014. PMID: 24463166 Hungarian.

4

[Small bowel stromal tumors diagnosed by capsule endoscopy].

Kovács M, Pák P, Uhlyarik A, Pák G, Török A, Gervain J, Fehér J. Kovács M, et al. Among authors: uhlyarik a. Orv Hetil. 2008 Apr 13;149(15):697-701. doi: 10.1556/OH.2008.28350. Orv Hetil. 2008. PMID: 18387874 Hungarian.

5

[Evaluation of diagnostic yield and clinical impact of capsule endoscopy in patients with obscure gastrointestinal bleeding].

Kovács M, Németh A, Pák P, Uhlyarik A, Pák G, Rácz I. Kovács M, et al. Among authors: uhlyarik a. Orv Hetil. 2006 Sep 24;147(38):1827-33. Orv Hetil. 2006. PMID: 17066599 Hungarian.

6

First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.

Kocsis J, Szekanecz É, Bassam A, Uhlyarik A, Pápai Z, Rubovszky G, Mezősi E, Rucz K, Garai I, Nagy E, Uray I, Horváth Z. Kocsis J, et al. Among authors: uhlyarik a. Exp Clin Endocrinol Diabetes. 2019 Apr;127(4):240-246. doi: 10.1055/s-0044-100378. Epub 2018 Mar 5. Exp Clin Endocrinol Diabetes. 2019. PMID: 29506310

7

[EGFR protein is a negative prognostic and predictive factor in wild-type RAS colorectal cancer].

Uhlyarik A, Piurkó V, Pápai Z, Rásó E, Lahm E, Kiss E, Sikter M, Vachaja J, Vízkeleti L, Kenessey I, Tímár J. Uhlyarik A, et al. Magy Onkol. 2021 Jun 3;65(2):121-127. Epub 2021 May 16. Magy Onkol. 2021. PMID: 34081760 Free article. Hungarian.

8

EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy.

Uhlyarik A, Piurko V, Papai Z, Raso E, Lahm E, Kiss E, Sikter M, Vachaja J, Kenessey I, Timar J. Uhlyarik A, et al. Cancers (Basel). 2020 Mar 6;12(3):614. doi: 10.3390/cancers12030614. Cancers (Basel). 2020. PMID: 32155907 Free PMC article.

9

EGFR Protein Expression of KRAS Wild-Type Colorectal Cancer: Predictive Value of the Sidedness for Efficacy of Anti-EGFR Therapy.

Uhlyarik A, Piurko V, Vizkeleti L, Pápai Z, Rásó E, Lahm E, Kiss E, Sikter M, Vachaja J, Kenessey I, Tímár J. Uhlyarik A, et al. Pathol Oncol Res. 2020 Jul;26(3):1429-1434. doi: 10.1007/s12253-018-00572-2. Epub 2019 Jan 5. Pathol Oncol Res. 2020. PMID: 30612313 Free article.

10

Regular chromogranin A monitoring facilitated the early detection of a gastrointestinal neuroendocrine tumour in a patient with type 1 diabetes.

Herold Z, Uhlyarik A, Herold M, Nagy P, Huszty GD, Rosta K, Doleschall M, Somogyi A. Herold Z, et al. Among authors: uhlyarik a. Endokrynol Pol. 2020;71(5):483-484. doi: 10.5603/EP.a2020.0054. Epub 2020 Aug 28. Endokrynol Pol. 2020. PMID: 32856287 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters